Engineering bacteria for cancer immunotherapy

We describe potential strategies to address this challenge, along with approaches for specific payload delivery and biocontainment to ensure safety. These strategies will pave the way for the development of cost-effective, widely applicable next-generation cancer therapeutics.PMID:38219524 | DOI:10.1016/j.copbio.2023.103061
Source: Current Opinion in Biotechnology - Category: Biotechnology Authors: Source Type: research